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 ULTRA SCALE-DOWN MIMICS FOR PERFUSION CULTURE 
MOLLY TREGIDGO1  DAVID POLLARD2  MARTINA MICHELETTI 1  
1Department of Biochemical Engineering, University College London, Torrington Place, London, WC1E 7JE 
2Merck Sharp Dohme, NJ, USA 
ABSTRACT 
EXPERIMENTAL METHODS BACKGROUND 
Media Optimisation Proof of Concept 
RESULTS  
Separation 
Efficiency (%) 
Sedimentation 96.9 
Centrifugation 94.5 
We would like to thank Nuno Pinto, Bill Napoli and Sen Xu at Merck 
Sharp Dohme, NJ, USA . 
 
Contact: molly.tregidgo.11@ucl.ac.uk 
With the industry considering the implementation of end to end continuous bioprocesses, there is a need for  the development of scale-down tools to provide the same 
consistency, reliability and throughput as the scale-down tools already available for traditional fed-batch processing. This work aims to develop a perfusion scale-down 
system capable of reproducing the specific  characteristics of the perfusion culture process, namely cell retention capabilities, the ability to support high cell densities and to 
operate for extended periods compared to fed-batch cultures. Cell culture in microwell plates in fed-batch mode is well defined and is in widespread use; however to the best 
of our knowledge this represents the first attempt at the development of quasi-perfusion cell culture at this scale.  
OBJECTIVES 
Quasi-Perfusion in microwell plates 
+ High throughput, low volume 
+ Ability to automate if desired 
− No on-line media or gas additions 
• Concerns O2 may become 
limiting at HCD 
 
Sedimentation  Centrifugation  
Separation  via Gravitational 
Settling (Size, 
Density) 
Accelerated 
Gravitational 
Settling (Size, 
Density) 
Advantages Low shear stress Separation time 
Disadvantages Separation time, 
Variability 
Higher shear stress 
CONCLUSIONS  FUTURE WORK  
1. Microwell plates are able to mimic many characteristics of perfusion culture, 
including elevated cell densities and high productivities,  O2  not yet limiting 
2. Sedimentation and Centrifugation quasi-perfusion cultures sensitive to media 
changes, promising for potential use in early phase development 
3. High cell densities are able to be maintained in the microwell system, as 
demonstrated by the stationary phase culture 
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1. Integration of microwell plate set up into automated liquid handling device in 
order to increase throughput and expand system application. 
2. Utilisation of the developed protocol in the screening of cell lines and media for 
perfusion culture applications.  
3. Set-up of a novel 250mL bioreactor to increase information output, maintain 
elevated cell densities for prolonged timescales and to operate continuously. 
1. Design of a perfusion culture mimic capable of achieving the characteristics of 
large scale culture. 
2. Implement developed quasi-perfusion techniques in microwell plate format. 
3. Demonstrate the use of quasi-perfusion in microwells as a tool for the early 
phase development of perfusion culture. 
 
 
c 
Evaluating ability to mimic 
perfusion culture 
1. Maintains elevated (high) cell 
density   
2. Cell retention  
3. Constant volume  
4. High productivity  
5. Continuous  
 
Quasi-perfusion cultures in 
microwell plates are promising for 
use in early development. Data 
across the 24 wells is consistent 
(data not shown) allowing multiple 
cell lines and media compositions 
to be investigated.  
 
Culture of GS-CHO in 24 round well plates at 37˚C, 220rpm  
Cells seeded at 2x106 cells/mL in ~1mL in CD-CHO media 
Fed-Batch Sedimentation Centrifugation 
2% bolus feeding of 
efficient feed B 
commencing on day 3 
for 5 consecutive days  
Sediment from day 3 
for ~30 min, 
exchange ~0.5mL 
media 2x daily 
Centrifuge from day 
3, exchange ~1mL 
media 1x daily 
Media exchange rate ~1 VVD 
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Fig. 1 Viable cell density and for Fed-Batch          and quasi-perfusion 
cultures  exchanged with CD-CHO media           and CD-CHO 
supplemented with glucose at 9g/L          and 12g/L 
Cells seeded at 40M cells/mL during the stationary 
phase. Determining the feasibility of using quasi-
perfusion methodology to mimic the stationary phase 
of perfusion cultures.  
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Improving cell densities by exchanging with CD-CHO supplemented with 
feeding media, increasing quantity of trace nutrients to alleviate limiting factor. 
Fig. 2. Viable cell density for Sed and Cent  quasi-perfusion cultures exchanged with CD-CHO 
supplemented with feeding media at 5%          15%           30%             and 45%  
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Total mAb Produced (g) 
     Feed B (%) 5 15 30 45 
Sedimentation 1.57 1.77 1.47 1.43 
Centrifugation 1.64 1.76 1.70 1.28 
Fig. 3. 
Average cell-
specific 
productivity 
for Fed-Batch 
and quasi-
perfusion 
cultures.  
Table 1. Total 
mAb produced 
over the culture 
duration for quasi-
perfusion cultures. 
Fed-Batch cultures produce a total of 1.06x10-3 g mAb, 
quasi-perfusion methods have 1000x greater 
volumetric productivity (with no impact on product 
quality – data not shown) 
0
0.5
1
1.5
2
2.5
3
0 2 4 6 8 10
La
ct
at
e
  (
g/
L)
 
Time (days) 
0
0.5
1
1.5
2
2.5
3
0 2 4 6 8 10
Time (days) 
Sedimentation Centrifugation 
Fig. 5. Viable cell density         and viability       for a stationary 
phase centrifugation quasi-perfusion culture exchanged using 
optimised media (media optimisation data not shown) 
Fig. 4. Glucose and 
Lactate profiles for 
quasi-perfusion 
cultures exchanged 
with CD-CHO 
supplemented with 
feeding media at      
5%           15%          
30%         and 45% 
Over-
supplementation in 
30and 45% cultures 
causes spikes high 
glucose 
concentrations. 
 
Lactate largely in 
expected range. 
 
